Videos

Together, let's share on the future approaches for the treatment of Resistant Hypertension

Video

Andrzej Januszewicz on Obstructive Sleep Apnea

Andrzej Januszewicz (Poland) answers the following questions: - Do you screen every hypertensive patient for obstructive sleep apnea and why or why not?…

Click here to watch

Click here to watch

Peter Blankestijn on Blood Pressure Measurement

Peter J. Blankestijn (Netherlands) answers the following questions: - Can you please explain the different modalities in measuring blood pressure, and the differences between home-based, office-based and ambulatory blood pressures?...

Click here to watch

Click here to watch

Ajay Kirtane on Treatment of Difficult to Control Hypertension in the US

Ajay Kirtane (United States) answers the following questions: - Can you tell us more about the treatment of difficult to control hypertension in the US and about the prevalence?...

Click here to watch

Click here to watch

Riaz Dawood - About resistant hypertension in South Africa

Riaz Dawood (South Africa) answers the following questions: - Please tell us about the prevalence of hypertension and especially resistant hypertension in South Africa...

Click here to watch

Click here to watch

Roland Schmieder - On the Symplicity HTN-3 press release and hypertension treatments

Roland Schmieder (Germany) answers the following questions: - Please share with us your thoughts on the Symplicity HTN-3 press release...

Click here to watch

Click here to watch

Markus Schlaich discussing the "fil rouge" patients presented during RHC 2014

Markus Schlaich (Australia) answers the following questions: - Can you tell us more about the RHC "fil rouge" patients presented in Berlin, and the objectives of using these patients?...

Click here to watch

Click here to watch

Renal denervation – Insights and directions

RHC 2014 Symposium - Learn how the pre-clinical and clinical evidence for catheter-based renal sympathetic denervation is continuing to be built, explore anatomical considerations in patient selection, and understand the importance multidisciplinary working in establishing appropriate and sustainable patient pathways

Click here to watch

Click here to watch

What are the key steps to evaluate a patient with uncontrolled hypertension?

RHC 2014 - This session comprehensively discusses the different modalities to measure blood pressure, assess the personalised patient risks, and it also includes key data for drug adherence.

Click here to watch

Click here to watch

What are the key mechanisms involved in hypertension?

RHC 2014 - Watch the recording of the first session presenting three typical patients with elevated blood pressure: - an elderly atherosclerotic patient (by R. Schmieder), - a metabolic patient (by M. Schlaich), - a young adrenergic patient (by K. Tsioufis).

Click here to watch

Click here to watch

Michel Burnier on Drug Adherence and Compliance

Michel Burnier (Switzerland) answers the following questions: - Please explain the difference between drug adherence and drug compliance...

Click here to watch

Click here to watch

Pages